Research & Development



  吳聞面有不悅地瞪了童百泉一眼,童村長咳嗽了兩聲出了廂房,吳聞同邢郎中也走了。大約又迷糊了一陣,有人壓低了聲音在黎斯耳邊道︰“醒了嗎?”   吳聞問︰“胖小子,你怎麼知道他叫黎斯?”caoporon免费超碰在线   “至于楊高軍和王冬,我也沒有打算放過他們。此前有一次跟李墨參加他的朋友聚會時,我認識了王冬的妻子毛淑娟。我努力地成為了她的閨蜜,為復仇做準備。人人澡人人碰在线播放   原來他是個病人……不對,我憑什麼要給個有病的男人當女朋友?   這胖小子像是個水壺,比小女孩還能哭,吳聞盯著福小生問︰“你爹讓你帶我們來見丁老財,對不對?”色久久综合桃花网   黎斯決定去丁宅里再查一查。丁宅里,黎斯道︰“先前調查丁宅,主要以正堂、廂房為主,這一次我們將範圍擴大到庭院和跨院,包括游廊和垂花門。”兩人簡單分工,吳聞調查前頭,黎斯負責後面。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo